AR064246A1 - Derivados de 5h-pirimido[5,4-d][2]benzazepinas inhibidores de la progresion mitotica,composiciones farmaceuticas que los contienen y usos como agentes anticancer. - Google Patents

Derivados de 5h-pirimido[5,4-d][2]benzazepinas inhibidores de la progresion mitotica,composiciones farmaceuticas que los contienen y usos como agentes anticancer.

Info

Publication number
AR064246A1
AR064246A1 ARP070105104A ARP070105104A AR064246A1 AR 064246 A1 AR064246 A1 AR 064246A1 AR P070105104 A ARP070105104 A AR P070105104A AR P070105104 A ARP070105104 A AR P070105104A AR 064246 A1 AR064246 A1 AR 064246A1
Authority
AR
Argentina
Prior art keywords
group
optionally substituted
heteroaryl
aryl
aliphatic
Prior art date
Application number
ARP070105104A
Other languages
English (en)
Spanish (es)
Inventor
Christopher F Clairborne
Todd B Sells
Stephen G Stroud
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39315133&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR064246(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of AR064246A1 publication Critical patent/AR064246A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
ARP070105104A 2006-11-16 2007-11-16 Derivados de 5h-pirimido[5,4-d][2]benzazepinas inhibidores de la progresion mitotica,composiciones farmaceuticas que los contienen y usos como agentes anticancer. AR064246A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85934006P 2006-11-16 2006-11-16

Publications (1)

Publication Number Publication Date
AR064246A1 true AR064246A1 (es) 2009-03-25

Family

ID=39315133

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070105104A AR064246A1 (es) 2006-11-16 2007-11-16 Derivados de 5h-pirimido[5,4-d][2]benzazepinas inhibidores de la progresion mitotica,composiciones farmaceuticas que los contienen y usos como agentes anticancer.

Country Status (34)

Country Link
US (7) US8026246B2 (Direct)
EP (4) EP2497772B1 (Direct)
JP (3) JP5102839B2 (Direct)
KR (2) KR101110458B1 (Direct)
CN (2) CN103483343B (Direct)
AR (1) AR064246A1 (Direct)
AT (1) ATE556076T1 (Direct)
AU (1) AU2007322046B2 (Direct)
BR (1) BRPI0718803B8 (Direct)
CA (1) CA2669680C (Direct)
CL (1) CL2007003244A1 (Direct)
CR (3) CR10782A (Direct)
CY (1) CY1112828T1 (Direct)
DK (2) DK2497772T3 (Direct)
EA (1) EA015779B1 (Direct)
ES (3) ES2384123T3 (Direct)
GE (1) GEP20125459B (Direct)
HR (2) HRP20120490T1 (Direct)
IL (1) IL198690A0 (Direct)
MA (1) MA30988B1 (Direct)
MX (3) MX343391B (Direct)
MY (1) MY153243A (Direct)
NO (1) NO343338B1 (Direct)
NZ (3) NZ611898A (Direct)
PH (1) PH12012502057B1 (Direct)
PL (2) PL2086981T3 (Direct)
PT (2) PT2497772E (Direct)
RS (2) RS52313B (Direct)
SG (2) SG176443A1 (Direct)
SI (2) SI2086981T1 (Direct)
TW (1) TWI401255B (Direct)
UA (1) UA94129C2 (Direct)
WO (1) WO2008063525A1 (Direct)
ZA (1) ZA200903279B (Direct)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120091275A (ko) 2004-05-14 2012-08-17 밀레니엄 파머슈티컬스 인코퍼레이티드 아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 방법
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
WO2010065134A1 (en) * 2008-12-05 2010-06-10 Millennium Pharmaceuticals, Inc. 5, 7-dihydro- 6h-pyrimido [ 5, 4-d] [ 1 ] benzazepin-6-thiones as plk inhibitors
KR101741168B1 (ko) * 2008-12-22 2017-05-29 밀레니엄 파머슈티컬스 인코퍼레이티드 오로라 키나아제 억제제 및 항­ｃｄ 항체의 병용
JO3635B1 (ar) * 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها
JO3434B1 (ar) * 2009-07-31 2019-10-20 Millennium Pharm Inc مركبات صيدلانية لمعالجة السرطان وامراض واضطرابات اخري
CN104031049A (zh) * 2010-02-19 2014-09-10 米伦纽姆医药公司 极光激酶抑制剂的结晶形式
US20120107304A1 (en) 2010-04-27 2012-05-03 Boehringer Ingelheim International Gmbh Combination therapy in treatment of oncological and fibrotic diseases
US9085582B2 (en) * 2010-06-22 2015-07-21 Glaxosmithkline Llc Benzotriazolodiazepine compounds inhibitors of bromodomains
TW201316991A (zh) * 2011-06-03 2013-05-01 Millennium Pharm Inc Ｍｅｋ抑制劑與奧諾拉（ａｕｒｏｒａ）ａ激酶選擇性抑制劑之組合
US20130303519A1 (en) 2012-03-20 2013-11-14 Millennium Pharmaceuticals, Inc. Methods of treating cancer using aurora kinase inhibitors
CN103772391A (zh) * 2012-10-23 2014-05-07 杨子娇 一类治疗房角狭窄的化合物及其用途
CN105209042B (zh) * 2013-03-22 2019-03-08 米伦纽姆医药公司 催化性mtorc 1/2抑制剂与选择性极光a激酶抑制剂的组合
JP6525474B2 (ja) 2013-12-06 2019-06-05 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． オーロラキナーゼ阻害剤と抗ｃｄ３０抗体の併用
EP3236948A4 (en) * 2014-12-23 2018-10-03 Millennium Pharmaceuticals, Inc. Combination of raf inhibitors and aurora kinase inhibitors
JP2018524292A (ja) 2015-07-21 2018-08-30 ミレニアム ファーマシューティカルズ， インコーポレイテッドＭｉｌｌｅｎｎｉｕｍ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． オーロラキナーゼインヒビターと化学療法剤の投与
JP6955485B2 (ja) 2015-09-09 2021-10-27 アイカーン スクール オブ メディスン アット マウント サイナイＩｃａｈｎ Ｓｃｈｏｏｌ ｏｆ Ｍｅｄｉｃｉｎｅ ａｔ Ｍｔ． Ｓｉｎａｉ 抗がん剤としての複素環式の限定された三環系スルホンアミド
JP6966425B2 (ja) 2015-09-09 2021-11-17 アイカーン スクール オブ メディスン アット マウント サイナイIcahn School of Medicine at Mt. Sinai 抗がん剤としての複素環式の限定された三環系スルホンアミド
WO2017146253A1 (ja) 2016-02-26 2017-08-31 公益財団法人がん研究会 Ｈｐ１の機能に着目した抗癌剤のスクリーニング方法及び評価系
CN109195593A (zh) 2016-03-15 2019-01-11 奥莱松基因组股份有限公司 用于治疗实体瘤的lsd1抑制剂的组合
JP6188986B1 (ja) * 2017-03-23 2017-08-30 株式会社ノエビア 時計遺伝子発現量調整剤及びエラスチン産生促進剤
US11874276B2 (en) 2018-04-05 2024-01-16 Dana-Farber Cancer Institute, Inc. STING levels as a biomarker for cancer immunotherapy
WO2020049208A1 (es) 2018-09-09 2020-03-12 Fundacio Privada Institut De Recerca De La Sida - Caixa Aurora cinasa como diana para tratar, prevenir o curar una infección por vih o sida
WO2021041532A1 (en) 2019-08-26 2021-03-04 Dana-Farber Cancer Institute, Inc. Use of heparin to promote type 1 interferon signaling
WO2023196959A1 (en) 2022-04-07 2023-10-12 Eli Lilly And Company Process for making a kras g12c inhibitor
CN119546309A (zh) 2022-04-08 2025-02-28 伊莱利利公司 包括kras g12c抑制剂和aurora a抑制剂的治疗方法
WO2024006424A1 (en) 2022-06-30 2024-01-04 Eli Lilly And Company Kras g12c inhibitor for treating cancer
WO2025075211A1 (en) 2023-10-03 2025-04-10 Takeda Pharmaceutical Company Limited Alisertib and paclitaxel for treating small cell lung cancer
WO2025245045A1 (en) 2024-05-21 2025-11-27 The Regents Of The University Of California Methods of treating lung cancer

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4099012A (en) * 1975-08-28 1978-07-04 Ciba-Geigy Corporation 2-pyrazolyl-benzophenones
US4481142A (en) * 1979-02-07 1984-11-06 Hoffmann-La Roche Inc. Pyrimido-2-benzazepines
CA1138863A (en) 1979-02-07 1983-01-04 Norman W. Gilman Benzazepine-derivatives
US4469633A (en) * 1980-05-16 1984-09-04 Hoffmann-La Roche Inc. N-oxides of 5-oxo-1-phenyl-2-benzazepines
EP0273697A3 (en) 1986-12-30 1989-11-29 Merck & Co. Inc. 2-benzazepines with 5- and 6- membered heterocyclic rings
US5166151A (en) * 1988-03-25 1992-11-24 Merck & Co., Inc. 2-Benzazepines with 5- and 6-membered heterocyclic rings, compositions and medical methods of use thereof
US5210082A (en) * 1991-05-16 1993-05-11 Merck & Co., Inc. 2-benzazepines with 5- and 6-membered heterocyclic rings to treat pain and anxiety disorders
GB9523675D0 (en) 1995-11-20 1996-01-24 Celltech Therapeutics Ltd Chemical compounds
US6124281A (en) * 1996-03-08 2000-09-26 Zeneca Limited Azolobenzazepine derivatives as neurologically active agents
WO1998028281A1 (en) * 1996-12-23 1998-07-02 Celltech Therapeutics Limited Fused polycyclic 2-aminopyrimidine derivatives, their preparation and their use as protein tyrosine kinase inhibitors
GB9713087D0 (en) 1997-06-20 1997-08-27 Celltech Therapeutics Ltd Chemical compounds
WO1999016770A1 (en) * 1997-09-29 1999-04-08 Meiji Seika Kaisha, Ltd. Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic
US6277844B1 (en) * 1998-09-14 2001-08-21 Sydney Spector Compound for selective treatment of malignant cells by inhibiting cell cycle progression, decreasing Bcl2, and increasing apoptosis
US6417207B1 (en) 1999-05-12 2002-07-09 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
DE60039782D1 (de) 1999-12-06 2008-09-18 Ajinomoto Kk Amidinophenylbrenztraubensäure-derivat
WO2002059111A2 (en) * 2000-12-21 2002-08-01 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
US6686352B2 (en) 2001-05-18 2004-02-03 Hoffmann-La Roche Inc. Substituted imidazo [1,5-a] pyrimido [5,4-d] [1] benzazepine derivatives
DE10135457A1 (de) * 2001-07-20 2003-02-06 Adc Automotive Dist Control Optische Sensoranordnung
KR100909122B1 (ko) 2001-08-09 2009-07-23 액테리온 파마슈티칼 리미티드 신규한 벤조-융합된 헤테로환
CN1897950A (zh) 2003-10-14 2007-01-17 惠氏公司 稠合芳基和杂芳基衍生物及其使用方法
KR20120091275A (ko) 2004-05-14 2012-08-17 밀레니엄 파머슈티컬스 인코퍼레이티드 아우로라 키나아제의 억제에 의해 유사분열 진행을 억제하기 위한 화합물 및 그 방법
BRPI0517737A (pt) 2004-11-17 2008-10-21 Miikana Therapeutics Inc inibidores de quinase
JP2008526723A (ja) 2004-12-30 2008-07-24 アステックス、セラピューティックス、リミテッド Ｃｄｋ、ｇｓｋ及びオーロラキナーゼの活性を調節するピラゾール誘導体
BRPI0620341A2 (pt) 2005-12-23 2011-11-08 Smithkline Beecham Corparation azaindóis inibidores de cinases aurora
US7718648B2 (en) 2006-08-09 2010-05-18 Millennium Pharmaceuticals, Inc. Pyridobenzazepine compounds and methods for inhibiting mitotic progression
CL2007003244A1 (es) 2006-11-16 2008-04-04 Millennium Pharm Inc Compuestos derivados de pirimido[5,4-d][2]benzazepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento del cancer.
JO3635B1 (ar) 2009-05-18 2020-08-27 Millennium Pharm Inc مركبات صيدلانية صلبة وطرق لانتاجها

Also Published As

Publication number Publication date
WO2008063525A1 (en) 2008-05-29
KR101110458B1 (ko) 2012-03-13
BRPI0718803B1 (pt) 2020-11-17
US20110312942A1 (en) 2011-12-22
CR20140154A (es) 2014-07-23
ZA200903279B (en) 2010-07-28
EP2086981A1 (en) 2009-08-12
CN101547924B (zh) 2013-09-25
PL2497772T3 (pl) 2015-05-29
CR20140544A (es) 2015-01-12
PL2086981T3 (pl) 2012-09-28
MX2009004670A (es) 2009-05-15
PT2086981E (pt) 2012-06-20
SG176443A1 (en) 2011-12-29
US8026246B2 (en) 2011-09-27
RS53788B1 (sr) 2015-06-30
PH12012502057A1 (en) 2015-09-14
ES2537451T3 (es) 2015-06-08
EA015779B1 (ru) 2011-12-30
JP5102839B2 (ja) 2012-12-19
US9988384B2 (en) 2018-06-05
EP2944639B1 (en) 2017-01-04
MX348568B (es) 2017-06-20
PH12012502057B1 (en) 2018-10-24
EP2497772B1 (en) 2014-10-29
KR101342014B1 (ko) 2013-12-19
US20240400567A1 (en) 2024-12-05
US20210214361A1 (en) 2021-07-15
EP2497773A1 (en) 2012-09-12
DK2086981T3 (da) 2012-08-06
EA200970486A1 (ru) 2009-10-30
SI2086981T1 (sl) 2012-12-31
HRP20150047T1 (en) 2015-03-13
TWI401255B (zh) 2013-07-11
UA94129C2 (ru) 2011-04-11
JP2014055166A (ja) 2014-03-27
JP5452811B2 (ja) 2014-03-26
CA2669680C (en) 2012-04-10
NO343338B1 (no) 2019-02-04
EP2086981B1 (en) 2012-05-02
CN103483343B (zh) 2016-06-01
ES2384123T3 (es) 2012-06-29
RS52313B (sr) 2012-12-31
BRPI0718803B8 (pt) 2021-05-25
TW200829589A (en) 2008-07-16
US20080167292A1 (en) 2008-07-10
HK1175777A1 (en) 2013-07-12
EP2944639A1 (en) 2015-11-18
PT2497772E (pt) 2015-02-05
MY153243A (en) 2015-01-29
CN103483343A (zh) 2014-01-01
US11958855B2 (en) 2024-04-16
SG10201503350TA (en) 2015-06-29
US10836766B2 (en) 2020-11-17
EP2497772A1 (en) 2012-09-12
KR20090091173A (ko) 2009-08-26
US20110312943A1 (en) 2011-12-22
DK2497772T3 (en) 2015-01-19
US9765076B2 (en) 2017-09-19
CL2007003244A1 (es) 2008-04-04
ATE556076T1 (de) 2012-05-15
HK1134672A1 (en) 2010-05-07
AU2007322046B2 (en) 2012-04-05
CY1112828T1 (el) 2016-02-10
GEP20125459B (en) 2012-03-26
AU2007322046A1 (en) 2008-05-29
CA2669680A1 (en) 2008-05-29
NZ597252A (en) 2013-06-28
CR10782A (es) 2009-06-24
ES2528793T3 (es) 2015-02-12
KR20110113210A (ko) 2011-10-14
JP2012006965A (ja) 2012-01-12
US20150166545A1 (en) 2015-06-18
EP2497773B1 (en) 2015-02-25
CN101547924A (zh) 2009-09-30
HK1217699A1 (en) 2017-01-20
MX343391B (es) 2016-11-04
US20190031662A1 (en) 2019-01-31
NZ611898A (en) 2015-01-30
NO20091864L (no) 2009-06-15
MA30988B1 (fr) 2009-12-01
HRP20120490T1 (hr) 2012-07-31
NZ577042A (en) 2012-03-30
HK1175778A1 (en) 2013-07-12
IL198690A0 (en) 2010-02-17
BRPI0718803A2 (pt) 2013-12-03
SI2497772T1 (sl) 2015-03-31
JP2010510215A (ja) 2010-04-02

Similar Documents

Publication Publication Date Title
AR064246A1 (es) Derivados de 5h-pirimido[5,4-d][2]benzazepinas inhibidores de la progresion mitotica,composiciones farmaceuticas que los contienen y usos como agentes anticancer.
AR078152A1 (es) Compuestos heterociclicos, utiles para el tratamiento de hcv y composiciones farmaceuticas que los comprenden
AR069772A1 (es) Derivados heterociclicos, una composicion farmaceutica y un juego que los comprenden y su uso en la preparacion de un medicamento para el tratamiento de una infeccion parasitaria.
CR10643A (es) DERIVADOS DE 2-ARIL-6-FENIL-IMIDAZOL[1,2-a]PIRIDINAS, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
AR072261A1 (es) Derivados piperazin-pirazolicos, composiciones farmaceuticas que los contienen y usos de los mismos como agentes anticancerigenos.
AR045260A1 (es) Compuestos que contienen imidazo-oxima sustituidos
ECSP12006640A (es) Inhibidores heterocíclicos de aspartil proteasa
ECSP088549A (es) Nuevos derivados de pirrol fusionado
AR077267A1 (es) Derivados nitrogenados heterociclicos inhibidores selectivos de pi3k, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades inflamatorias y/o autoinmunes.
AR035669A1 (es) Imidazoquinolinas y 6,7,8,9-tetrahidroimidazoquinolinas, composiciones que las comprenden, y usos de dichos compuestos en la preparacion de medicamentos
AR083199A1 (es) Compuestos de n-heteroarilo con unidad de puente ciclico
AR048641A1 (es) Compuestos de aril- o heteroarilamida ortosustituidos utiles como antago-nistas del receptor de prostaglandinas e2; composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicame
AR063602A1 (es) Derivados de espiroindolinona, formulaciones farmaceuticas que los contienen y su uso en la obtencion de un medicamento para el tratamiento de trastornos oncologicos.
AR038240A1 (es) Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para su preparacion
PE20120106A1 (es) Moduladores de receptores tipo toll
ECSP11011555A (es) Sulfonamidas heterocíclicas, usos y composiciones farmacéuticas de las mismas
ECSP066643A (es) PIRIDO [2,3-d] PIRIMIDINA-2,4-DIAMINAS COMO INHIBIDORES DE PDE 2
AR067176A1 (es) Compuesto de benzazepina y preparacion farmaceutica
AR083200A1 (es) Compuestos de n-heteroarilo
UY29393A1 (es) Nuevos derivados de amidas, sales farmacéuticas aceptables, composiciones que los contienen, procedimientos de preparación y aplicaciones.
NI201000134A (es) Nuevos derivados dihidroindolonas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
UY30933A1 (es) Derivados de pentafluorotiobenzamidoacetonitrilo, composiciones farmacéuticas que contienen tales compuestos y aplicaciones.
CL2008003639A1 (es) Compuestos derivados de amida; composición farmacéutica que comprende a dicho compuesto; combinación farmacéutica; y uso del compuesto en el tratamiento del vih.
NI200900147A (es) Nuevos derivados tricíclicos su procedimiento de preparación y las composiciones farmacéuticas que los contienen.
ECSP088257A (es) Derivados de amida

Legal Events

Date Code Title Description
FB Suspension of granting procedure